S

Syngene International Ltd

Labs & Life Sciences ServicesSmallcap

About the company

Syngene International Limited is a contract research company. It is engaged in providing contract research and manufacturing services in early-stage drug discovery and development to pharmaceutical and biotechnology companies.

Performance

Stock
Loading Stock value

Analyst Ratings and Key Metrics

Based on 8 analysts offering recommendations for Syngene International Ltd

63%

Buy

25%

Hold

12%

Sell

Key MetricsThis StockCategory (Avg)
PE Ratio57.5840.87
PB Ratio3.866.09
Dividend Yield0.28%0.57%

Understand what these metrics mean. 

Equity investments are subject to market risks. Read all the related documents carefully before investing. By using this page, you agree to the Terms & Conditions